FFL’s Karen Winterhof: slow, banker-driven dealflow makes proprietary opportunities more important

'Demonstrated ability to improve patient outcomes while helping to take costs out of the system will be key for us.'

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this